Cambridge Investment Research Advisors’s Innovator US Equity Buffer ETF October BOCT Stock Holding History
Bought
Maintained
Sold
Other funds holding BOCT
PCM
CA
IIA
OMC
Cambridge Investment Research Advisors's BOCT Position: Q2 2026 in Review
Cambridge Investment Research Advisors increased its Innovator US Equity Buffer ETF October (BOCT) stake by 4.6% in Q2 2026, buying an estimated $86.2K and bringing the position to 38,000 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1684.
Cambridge Investment Research Advisors first reported a position in BOCT in Q3 2019 and has held it in 28 quarters since. The position peaked at $2.19M in Q4 2023. 121 funds tracked by Wall St. Rank hold BOCT as of Q2 2026.
- Cambridge Investment Research Advisors held 38,000 shares of Innovator US Equity Buffer ETF October worth $2.02M as of Q2 2026.
- Cambridge Investment Research Advisors bought 1,667 Innovator US Equity Buffer ETF October shares in Q2 2026, an estimated $86.2K.
- Innovator US Equity Buffer ETF October made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1684 holding.
- Cambridge Investment Research Advisors first reported a position in Innovator US Equity Buffer ETF October in Q3 2019 and has held it in 28 quarters since.
- Cambridge Investment Research Advisors's Innovator US Equity Buffer ETF October position peaked at $2.19M in Q4 2023.
- 121 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF October as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.